We describe two patients with homozygous EIF2AK4-associated PVOD, who despite typical clinical features at presentation have demonstrated a remarkable response to pulmonary vasodilator therapy and comparatively benign clinical courses. The gene discussed is EIF2AK4; the disease is pulmonary venoocclusive disease.